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Supercomplexctions have been identiﬁed in X-ray structures of membrane proteins. The role of
speciﬁcally bound lipid molecules in protein function remains elusive. In the current study, we investigated
how phospholipids inﬂuence catalytic, spectral and electrochemical properties of the yeast respiratory
cytochrome bc1 complex and how disruption of a speciﬁc cardiolipin binding site in cytochrome c1 alters
respiratory supercomplex formation in mitochondrial membranes. Puriﬁed yeast cytochrome bc1 complex
was treated with phospholipase A2. The lipid-depleted enzyme was stable but nearly catalytically inactive.
The absorption maxima of the reduced b-hemes were blue-shifted. The midpoint potentials of the b-hemes
of the delipidated complex were shifted from−52 to−82 mV (heme bL) and from +113 to−2 mV (heme
bH). These alterations could be reversed by reconstitution of the delipidated enzyme with a mixture of
asolectin and cardiolipin, whereas addition of the single components could not reverse the alterations. We
further analyzed the role of a speciﬁc cardiolipin binding site (CLi) in supercomplex formation by site-
directed mutagenesis and BN-PAGE. The results suggested that cardiolipin stabilizes respiratory super-
complex formation by neutralizing the charges of lysine residues in the vicinity of the presumed interaction
domain between cytochrome bc1 complex and cytochrome c oxidase. Overall, the study supports the idea,
that enzyme-bound phospholipids can play an important role in the regulation of protein function and
protein–protein interaction.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Lipids are essential components of every cell. Lipid bilayers form
boundaries to separate different cell compartments and they provide
the matrix for membrane-spanning proteins. A vast number of studies
suggest that speciﬁc association of lipids with membrane proteins can
contribute to functional aspects of the protein [1] affecting, for
instance, enzyme activity [2], channel function [3] and drug action [4].
Only recently has it been possible to obtain crystal structures of
membrane proteins with sufﬁcient resolution to identify bound lipids.
It is now recognized that retained or supplemented lipids are
important for integrity and successful crystallization of membraneX, cytochrome c oxidase; BN-
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the phosphodiester of lipid head groups and a speciﬁc cardiolipin (CL,
bisphosphatidyl glycerol) binding motif have been deduced from
available membrane protein structures [6,7]. Identiﬁcation of speciﬁc
lipid-binding sites enables analysis by site-directed mutagenesis to
understand the role of bound phospholipids. For example, altering the
primary ligand of the interhelical phosphatidyl-inositol in the yeast
cytochrome bc1 complex (cyt bc1 complex) destabilizes the interac-
tion of the Rieske protein subunit with the catalytic core of the
enzyme [8]. Mutational analysis of a conserved lipid-binding site in
subunit III of the cytochrome c oxidase (COX) from Rhodobacter
sphaeroides identiﬁed by X-ray crystallography [9] points to a crucial
role of the bound lipid in the interaction of subunit I and III [10].
The role of speciﬁc protein–lipid interactions have been studied in
the mitochondrial cyt bc1 complex (ubiquinol:cytochrome c oxidor-
eductase, EC 1.10.2.2, complex III). The multi-subunit protein complex
embedded in the inner mitochondrial membrane catalyzes the
transfer of electrons from membrane-localized ubiquinol to water-
soluble cytochrome c (cyt c). This redox reaction is coupled to
translocation of protons across the membrane. The mechanism that
links proton translocation to electron transfer, the protonmotive Q
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ubiquinol and ubiquinone, both located in the cytochrome b (cyt b)
subunit. The key step of the mechanism is the bifurcated route of the
two electrons released upon ubiquinol oxidation at the Qo site. One
electron is transferred into the high potential chain, the 2Fe–2S cluster
Rieske protein (ISP) and cytochrome c1 (cyt c1), and subsequently
delivered to cyt c. The second electron is transferred via the low
potential chain, heme bL and heme bH of cyt b to the Qi site, where
quinone is reduced to semiquinone. For a complete turnover of the
enzyme, a second ubiquinol molecule is oxidized in the same way so
that the Qi-site semiquinone is reduced and an ubiquinol leaves this
pocket. X-ray structures from the bovine [12,13], avian [14] and yeast
[15–17] complexes provided critical information for elucidation of
mechanism and structure/function relationships [5,18–20].
Phospholipids are essential for the function of the cyt bc1
complex. Delipidation of the bovine complex leads to reversible
loss of catalytic activity [21,22]. Restoration of activity depends on CL
leading to the postulate that “CL is either essential for catalytic
function, or that it acts as an allosteric ligand that stabilizes the fully
active conformation” [23]. Several tightly bound phospholipids
including CL were identiﬁed in X-ray structures of the yeast cyt bc1
complex [7,8,24] (Fig. 1A, B). Less detergent in solubilisation and
chromatography steps increased the number of structurally resolved
endogenous lipids [17]. Destabilization of individual phospholipid-
binding sites in the yeast cyt bc1 complex by site-directed mutagen-
esis, suggested that these phospholipids are important for the
structural and functional integrity of the membrane protein [8].
One CL molecule is found in a depression formed by cyt b, cyt c1, and
ISP close to the site of ubiquinone reduction, the Qi site. It is mainly
stabilised by residues K288, K289 and K296 of subunit cyt c1. This CL
molecule, henceforth addressed as CLi (see Fig. 1B) appears to
stabilize the architecture of the proton conducting environment at
the Qi site and may be involved in proton uptake [8,25]. Phospho-
lipids and especially CL, which is in non-photosynthetic eukaryotes
exclusively found in the inner mitochondrial membrane, are also
important for the supramolecular association of the cyt bc1 complex
with COX. In yeast, CL deﬁciency causes destabilization of super-
complexes [26].Fig. 1. Yeast cyt bc1 complex with bound lipids (PDB entries 1P84, 3CX5). (A) Overview of th
grey. Lipids are presented as sphere models in yellow and cardiolipin (CL) is highlighted in
phospholipids are labelled according to [7] and their head groups are truncated to phosph
ubiquinone (Q) and heme bH is surrounded by lipids including the surface exposed CLi and th
high-resolution structure. (B) Detailed view of the CLi-binding site close to the Qi site. Subuni
interacting with CLi are shown as stick models in orange with blue nitrogen atom. ResidualIn the present work, we investigate in detail the effects of
enzymatic delipidation of the yeast cyt bc1 complex on its catalytic,
spectral and electrochemical properties. We further analyzed, if
alterations in the delipidated enzyme can be reversed by addition of
phospholipids. Additionally, the role of the speciﬁc CLi-binding site of
yeast cyt bc1 complex for the formation of respiratory supercomplexes
was examined by site-directed mutagenesis and BN-PAGE analysis.
2. Materials and methods
2.1. Media and yeast strains
Premixed media were from ForMedium. Yeast strains were grown
in YPG (1% yeast extract, 2% peptone and 3% glycerol) and/or in media
containing 3% lactate in 5 l bafﬂed ﬂasks (2 l culture volume) at 30 °C
and 220 rpm to OD550 of 8–10. Generation of expression plasmids for
lysine substitutions of the cyt c1 subunit of the cyt bc1 complex has
previously been described [8]. The plasmids containing wild-type and
mutated CYT1 genes were transformed into the yeast strain LLD6, in
which the CYT1 gene is deleted [8]. Additionally, the plasmids were
also transformed into a yeast strain, in which both the CYT1 and the
CRD1 (cardiolipin synthase) genes are deleted. This strain was
constructed by targeted substitution of the CRD1 gene in LLD6 by a
kanMX4 cassette using the plasmid pYORC_YDL142c, which was
obtained from Euroscarf. The strains used in this study are listed in
Table 1.
2.2. Phospholipids
Asolectin from soybean and cardiolipin from bovine heart were
obtained from Sigma. Asolectin contains roughly equal proportions of
lecithin, cephalin and phosphatidyl-inositol with minor amounts of
other phospholipids and polar lipids.
2.3. Puriﬁcation of cytochrome bc1 complex
The wild-type yeast strain was grown in YPG medium.
Mitochondrial membranes were prepared as described [27]. Cyte dimeric structure with one functional monomer in blue and the other in transparent
orange. All atoms of phosphate groups are shown in red. With the exception of CL all
ate for clarity. L4 and L6 reﬂect the position of the membrane bilayer. The Qi site with
e central CLc [24]. The latter was resolved at the centre of the monomer interface in the
t cyt c1 is shown as orange cartoon representation and its residues K288, K289 and K296
protein subunits are presented as surface model and colors are as described above.
Table 1
Yeast strains used for the analysis of CLi-dependent supercomplex formation.
Name Genotype Reference
LLD6 (= Δcytc1) Mat a, Ade2–1, his3–11 and 3–15,
trp 1–1, leu 2–3 and 2–112,
ura 3–1, can 1–100, cytc1∷His
[38]
wt LLD6 [wt Cytc1] [8]
K288L LLD6 [K228L Cytc1] [8]
K289L LLD6 [K289L Cytc1] [8]
K296L LLD6 [K296L Cytc1] [8]
K288L/K289L LLD6 [K288L/K289L Cytc1] [8]
K288L/K296L LLD6 [K288L/K296L Cytc1] [8]
K289L/K296L LLD6 [K289L/K296L Cytc1] [8]
K288L/K289L/K296L LLD6 [K288L/K289L/K296L Cytc1] [8]
Δcrd LLD6 crd1∷kanMX4 [wt Cytc1] This study
Δcrd/K228L Δcrd [K228L Cytc1] This study
Δcrd/K289L Δcrd [K289L Cytc1] This study
Δcrd/K296L Δcrd [K296L Cytc1] This study
Δcrd/K288L/K289L Δcrd [K288L/K289L Cytc1] This study
Δcrd/K288L/K296L Δcrd [K288L/K296L Cytc1] This study
Δcrd/K289L/K296L Δcrd [K289L/K296L Cytc1] This study
Δcrd/K288L/K289L/K296L Δcrd [K288L/K289L/K296L Cytc1] This study
Single, double and triple leucine replacements of the cyt c1 residues K288, K289 and
K296, the primary stabilizing ligands of CLi, were analyzed in a CL-wild type (LLD6) and
a CL-deﬁcient strain (Δcrd1).
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exchange chromatography steps as described previously [27].
Membranes were solubilized at a protein concentration of
10 mg/ml with 1.5% dodecyl-maltopyranoside. The detergent was
exchanged to 0.05% (w/v) undecyl-maltopyranoside (UM) at the
second DEAE step.
2.4. Redox spectroscopy and quantiﬁcation of cytochrome bc1 complex
Wild-type, delipidated and relipidated complexes were diluted to
∼10 μM in assay buffer (see below). Redox difference spectra were
quantiﬁed using extinction coefﬁcients of 17.5 mM−1 cm−1 for
ascorbate-reduced minus ferricyanide-oxidized c-heme (553–
540 nm) and 25.6 mM−1 cm−1 for dithionite-reduced minus
ferricyanide-oxidized b-hemes (562–575 nm).
2.5. Delipidation and relipidation
Puriﬁed cyt bc1 complex was diluted to 15 μM in 2 mM CaCl2,
50 mM Tris–HCl pH 7.4, 250 mM NaCl, 0.05% UM. The enzyme was
delipidated by incubation with 66 U/ml phospholipase A2 (porcine
pancreatic, Sigma) for 1 h at room temperature. Delipidation was
stopped by addition of 10 mM EDTA. For relipidation, asolectin or
cardiolipin or a mixture of both lipids was added from 2% (w/v)
soniﬁed lipid/water suspensions to 15 μM cyt bc1 complex at a
ﬁnal concentration of 132 μM and 69 μM for asolectin and
cardiolipin, respectively, and incubated for 1 h at RT. The
enzyme/lipid mixture was used immediately or stored at 4 °C for
a maximum of 3 days.
2.6. Measurement of ubiquinol–cytochrome c reductase activity
Puriﬁed cyt bc1 complex was assayed in 50 mM potassium
phosphate pH 7.4, 250 mM sucrose, 1 mM KCN, 0.05% UM, and
50 μM horse heart cyt c at room temperature for ubiquinol-
dependent cyt c reductase activity. The enzyme was diluted to
2.5–10 nM in assay buffer and the reaction was started with
40 μM decylubiquinol. Reduction of cyt c was monitored at
550 nm versus 540 nm in dual wavelength mode and the rate of
cyt c reduction was calculated using an extinction coefﬁcient of
21.5 mM−1 cm−1. Turnover numbers are expressed as mol cyt c
reduced per mol cyt bc1 complex monomer per second under
steady-state condition.2.7. Spectroelectrochemistry
An ultrathin layer spectroelectrochemical cell for the UV/Vis range
was used as previously described [28]. Cyt bc1 complex samples with
different lipid content were used at a concentration of ∼70 mg/ml in
50 mM Tris pH 7.3, 250 mM NaCl, 0.05% UM. The gold grid working
electrode was chemically modiﬁed with a 1:1 mixture of 2 mM
cysteamine and 2 mM mercaptopropionic acid solution and 16
different mediators were added to a ﬁnal concentration of 45 μM
each to accelerate the redox reaction as reported previously [29].
Potentials were measured with an Ag/AgCl/3M KCl reference
electrode and are quoted in reference to the standard hydrogen
electrode at pH 7.0.
The redox dependent signal of each heme could be differentiated
in electrochemically induced UV/Vis difference spectra, on the basis of
the relative contribution of the hemes bL, bH and c1 to each position in
the alpha band. The contributions were obtained on the basis of redox
titrations that were performed by stepwise setting of potentials and
recording the spectrum after equilibration. Typically, data were
recorded using 50 mV steps between –0.29 V and 0.71 V. All
measurements were performed at 5 °C. The pH was adjusted in
50 mM Tris buffer (pH 7.3). The reference electrode was calibrated
with the cyclovoltammogram of a buffered K4[Fe(CN)6] solution
before the potential titration was started. All electrochemical titra-
tions were reversible as controlled by directly comparing fully
oxidized minus fully reduced visible difference spectra at different
points in the experiments. Data analysis was carried out with a
program developed by S. Grzybek termed EHTIT [30], in which the
midpoint potentials Em and the number n of the transferred electrons
were obtained by adjusting a calculated Nernst curve to the measured
absorbance change at a chosen single wavelength (563 nm, where all
three hemes contribute), using the best ﬁt for data evaluation. This
analysis was conﬁrmed for several wavelengths. Typically, an n value
of about 0.9 was found for each heme. Electrochemically induced
difference spectra were recorded and processed as previously
described [29].
2.8. Analysis of respiratory supercomplex formation in yeast
mitochondria by blue native electrophoresis
Yeast strains listed in Table 1 were grown with lactate as a
carbon source. Mitochondria were then isolated as described [31]
and stored at −80 °C as 400 μg aliquots. Mitochondrial pellets were
solubilized for BN-PAGE using a digitonin/protein ratio of 3 g/g as
described previously [32]. Equal protein amounts based on Lowry
assay were loaded on all gels. Following BN-PAGE, 0.5 cm strips
from BN-PAGE were excised and analyzed in a second dimension by
Tricine-SDS-PAGE [33].
3. Results
3.1. Delipidation of yeast cytochrome bc1 complex
Detergent solubilised and puriﬁed yeast cyt bc1 complex contains
at least six tightly bound phospholipid molecules per enzyme
monomer as resolved in X-ray structures of the complex [7,8,24].
Residual electron density in these structures suggests the presence of
additional less ordered lipids. Phospholipase A2 cleaves the acyl bond
at the sn-2 position in phospholipids generating lyso-phospholipids
and fatty acids. Treatment of the bovine cyt bc1 complex with this
enzyme resulted in a lipid-depleted and inactive protein [23].
Following this protocol, puriﬁed yeast cyt bc1 complex was incubated
with phospholipase A2 to remove enzyme-bound phospholipids. The
extent of delipidation was followed by monitoring the decrease of cyt
c reductase activity in 10 min intervals. After 1 h incubation, the
turnover number has decreased to about 10% of the original value
Fig. 3. Spectral properties of wild-type, delipidated and relipidated yeast cyt bc1
complex. Difference spectra were recorded for sodium dithionite-reduced vs ferricya-
nide-oxidized cyt bc1 complex. The solid line indicates the alpha-band maximum of
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further decrease. Incubation of the native enzyme with EDTA-
inactivated phospholipase did not alter the catalytic activity.
Delipidated bovine cyt bc1 complex can be repuriﬁed by anion
exchange chromatography without apparent destabilization of the
multi-subunit complex [23]. In contrast, repuriﬁcation attempts of the
delipidated yeast complex resulted in aggregation of the protein. Yet,
the phospholipase-delipidated complex was stable for one week at
4 °C and in this time frame no aggregation of the protein or loss of
subunits was observed as judged by SDS-PAGE and Western blot
analysis (data not shown). Therefore, the delipidated complexwas not
further puriﬁed and used in mixture with the EDTA-inactivated
phospholipase for further analysis.
3.2. Effects of delipidation and relipidation on cytochrome c reductase
activity
The delipidated, nearly inactive but stable yeast cyt bc1 complex
was incubated for 1 h with asolectin or cardiolipin or a mixture of
both. The ﬁnal concentrations were 15 μM complex and 0.01% total
lipid. Addition of asolectin resulted only in a minor increase of the
enzyme activity (Fig. 2). Increasing amounts of asolectin or prolonged
incubation did not further enhance the turnover number (data not
shown). Upon addition of cardiolipin to the delipidated complex, the
enzyme activity increased to about 20% of the wild-type complex (Fig.
2). As with the asolectin treatment, increasing amounts of CL or a
longer incubation time did not lead to further reactivation. Addition of
a high excess of phospholipids to the delipidated complex resulted in
precipitation of the enzyme. Maximum reactivation of the delipidated
enzyme was observed after addition of a mixture of asolectin and
cardiolipin. About 70% of the original turnover number could be
restored (Fig. 2). Addition of asolectin, CL or the asolectin/CL mixture
to the untreated enzyme did not alter its activity.
3.3. Effects of delipidation and relipidation with different phospholipids
on the redox-spectroscopical characteristics of the cytochrome bc1
complex
Redox spectra of the untreated, delipidated and relipidated
complex were recorded to analyze perturbations of the heme
cofactors upon delipidation. The delipidation caused a blue shift of
the b-heme absorption maximum from 563 nm in the untreated wild-
type enzyme to 561 nm in the delipidated enzyme (Fig. 3).
Delipidation-related changes in the c-heme absorption maximumFig. 2. Cyt c reductase activity fromwild-type, delipidated and relipidated yeast cyt bc1
complex. Relative turnover numbers are shown for the wild-type enzyme (wt),
delipidated enzyme (delip), relipidated enzyme with asolectin (aso), CL (CL), or a
mixture of asolectin and CL (aso/CL) added. The rate of thewild-type cyt bc1 complex is
referred to as 100% value. The assay was carried out according to the standard protocol
with 10 nM cyt bc1 complex, 50 μM cyt c and 40 μM decylubiquinol. The values are the
average of ﬁve measurements.
cyt b in the wild-type enzyme, the dashed line in the phospholipase-treated enzyme.were not resolved. Addition of asolectin to the delipidated enzyme did
not change the position of the b-hememaximum at 561 nm. However,
relipidation with cardiolipin caused a slight shift of the b-heme
maximum to 562 nm. Upon addition of a mixture of asolectin and
cardiolipin, the position of the b-heme maximumwas nearly identical
to the untreated enzyme demonstrating reversibility of the blue shift
(Fig. 3). Addition of asolectin, CL or the asolectin/CL mixture to the
untreated enzyme did not alter the position of the b-heme alpha-band
maximum (data not shown).
3.4. Effects of delipidation and relipidation with different phospholipids
on the midpoint redox potentials of the b-hemes
For further characterization of the lipid-cofactor interplay, the
midpoint redox potentials of the heme groups were determined as
described in Material and methods for untreated, delipidated and
relipidated cyt bc1 complex. Fig. 4 shows the redox titration curves of
the native untreated complex (A) in direct comparison to the lipid-
depleted complex (B) and after supplementation of the complex with
Fig. 4. Potential titrations of cyt bc1 complex samples as isolated (A), delipidated (B),
relipidated with asolectin and CL (C), relipidated with asolectin (D), and with CL (E)
only. Oxidative and reductive titrations were fully reversible. For details see Materials
and methods and Table 2.
Table 2
Midpoint redox potentials (mV) for wild-type (WT), delipidated and relipidated yeast
cyt bc1 complex vs. standard hydrogen electrode at pH 7.0.
Heme bL Heme bH Heme c1
WT −52 113 278
delipidated −82 −2 278
+ asolectin −51 26 285
+ cardiolipin −42 64 250
+ asolectin/cardiolipin −46 48 266
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and cardiolipin (E) alone. The midpoint potential of heme bH of the
untreated enzyme was 113 mV, whereas it was strongly shifted to the
negative (Em=−2 mV) in the lipid-depleted complex. This shift
could be partially reversed (to Em=26mV) by addition of asolectin to
the delipidated enzyme. Addition of cardiolipin further raised the
midpoint potential to 64 mV. Relipidation with the mixture of
asolectin and CL raised the midpoint potential for heme bH to 48 mV
(Table 2).
The Em of heme bL was−52 mV for the untreated enzyme. A slight
shift to a more negative value of −82 mV was determined for the
lipid-depleted cyt bc1 complex. In the asolectin treated enzyme, the
midpoint potential was −51 mV. Addition of CL to the delipidated
enzyme gave rise to a midpoint potential of −42 mV, similar to the
effect of the asolectin/CL mixture (−46 mV).
An Em of 278 mV was determined for heme c1 of the untreated
enzyme. No major changes were observed after lipid depletion or
relipidation with asolectin, CL or a mixture of asolectin and CL. The
midpoint potentials are summarized in Table 2.
3.5. Role of CLi for supercomplex formation and stability
CL does not only inﬂuence the catalytic activity of the cyt bc1
complex and the environment of the cofactors, but it has also been
shown to be important to stabilize the supramolecular interaction
between cyt bc1 complex and COX. The CLi molecule speciﬁcallybound close the Qi site of the cyt bc1 complex was suggested to be
involved in linking the two complexes together [26]. Residues
K288, K289 and K296 of subunit cyt c1 are the primary ligands of
CLi (Fig. 1B). Their side chains interact with one phosphodiester
group. To investigate the role of this speciﬁc CL, one, two or all
three lysines had been substituted by leucine [8]. While the single
mutations did not have a measurable effect on the ubiquinol:cyt c
reductase activity, double and triple replacements resulted in a
slow growth phenotype on non-fermentable carbon sources corre-
lated with a lower cyt bc1 complex content in mitochondrial
membranes. All single, double and triple replacement mutants were
now re-analysed with respect to supercomplex stabilization in
mitochondrial membranes. Loss of positively charged lysine(s) was
expected to reduce the afﬁnity for the negatively charged CL,
eventually leading to loss of CLi-binding and potentially to destabi-
lization of the cyt bc1 complex:COX supercomplex. In addition,
another set of yeast strains was constructed, which carried the same
replacement variants but in a CL-free background. This was achieved
by a knockout of the cardiolipin synthase (CRD1) in the nuclear
genomic DNA. All analyzed variants are listed in Table 1.
Mitochondrial membrane preparations of each variant grown on
lactate were analyzed by BN-PAGE and 2-D BN/SDS-PAGE. The wild-
type (WT) (Fig. 5A, upper panel) and selected CL-containing variants
containing one (K289L), two (K288L/K289L) and three (K288L/
K289L/K296L) replacements (Fig. 5B–D, upper panels) were com-
pared with the corresponding variants in a CL-free background (Fig.
5A–D, lower panels). For WT yeast (Fig. 5A, upper panel), larger
supercomplex (L) comprising dimeric cyt bc1 complex and two copies
of COX was the predominant respiratory supercomplex. Yeast
respiratory supercomplexes have been previously characterized
[26,34] so that the type of supercomplex can be deduced from its
position relative to the monomeric and dimeric ATP synthase and the
detection of some cyt bc1 complex and/or COX subunits. Smaller
supercomplex (S) was hardly detectable. All CL-containing lysine
variants (Fig. 5B–D, upper panels) also contained respiratory super-
complexes but there was a clear shift to the smaller supercomplex. For
the triple replacement variant, also individual complexes cyt bc1
complex and COX (red and green arrows, respectively, in Fig. 5D,
upper panel) were observed after BN-PAGE. The results are consistent
for the other single and double replacements (data not shown). These
ﬁndings indicate that CL at the speciﬁc CLi-binding site, which is most
likely not occupied in triple (and double) replacement variants,
contributes considerably to the stability of supercomplexes but is not
essential for their formation.
A supercomplex stabilizing role for CLi is suggested by the analysis
of CL-free variants. In the CL-free environment, no stable super-
complex formation could be observed with the wild-type complex
(Fig. 5A, lower panel) as shown before [26]. Introducing one single
lysine replacement, i.e. the loss of one positive charge, could not
restore supercomplex stability, as exempliﬁed with the K289L variant
in Fig. 5B, lower panel. Results for the K288L and K296L single
replacement variants were highly similar (not shown). However,
supercomplex stability was found to be restored in two double
replacement variants, namely in the K288L/K289L variant, as shown
in Fig. 5C, lower panel, and in the K289L/K296L variant (not shown)
Fig. 5. Analysis of respiratory supercomplexes with mutations in the speciﬁc CLi-binding site of cyt c1 from CL-containing (upper panels) and CL-deﬁcient yeast mitochondria (lower
panels). Mitochondrial complexes from parental andmutant strains grown on lactate were solubilized with digitonin and separated by BN-PAGE. The subunits were then resolved by
SDS-PAGE in the second dimension. Some characteristic subunits of cyt bc1 complex (labelled QCR) and COX are indicated in red and green, respectively. The α and β subunits of ATP
synthase are marked black. Horizontal and diagonal red and green arrows point to subunits of cyt bc1 complex and COX in respiratory supercomplexes and individual complexes,
respectively. M, D, monomeric and dimeric ATP synthase; L, S, larger and smaller respiratory supercomplexes; III, IV, individual cyt bc1 complex and COX, respectively; Vac, vacuolar
ATPase; F1, F1-part of ATP synthase. (A)Mitochondria from a CL-synthesizing (WT+CL) and a CL-deﬁcient (WT−CL) parental strainwere used. (B) Analysis of the K289L variant of cyt c1
from CL-synthesizing (K289L +CL) and CL-deﬁcient (K289L −CL) strains. (C) Analysis of the K288L/K289L double replacement in cyt c1 from CL-synthesizing (K288L/K289L +CL)
and CL-deﬁcient (K288L/K289L −CL) strains. (D) Analysis of the K288L/K289L/K296L triple replacement in cyt c1 from CL-synthesizing (3×KL +CL) and CL-deﬁcient (3×KL −CL)
strains.
614 T. Wenz et al. / Biochimica et Biophysica Acta 1787 (2009) 609–616but not in the K288L/K296L variant (not shown). Supercomplexes
were identiﬁed also for the triple replacement variant, although the
detection of free COX (green arrows in Fig. 5D, lower panel) pointed to
reduced stability of supercomplexes.
4. Discussion
Information obtained from high-resolution X-ray structures of
membrane proteins in recent years has highlighted an intimate
relationship between these proteins and membrane lipids. Structu-
rally resolved lipids with tight and speciﬁc binding sites appear to be
important for structural and functional integrity of membrane
proteins, yet the role of individual lipids and the underlying
mechanism remain elusive so far. In this work, we investigated the
effect of bound phospholipids on the function and biophysical
properties of the yeast cyt bc1 complex and on its supramolecular
assembly with COX in mitochondrial membranes.
Enzymatic delipidation of the yeast cyt bc1 complex was used to
analyze effects on the catalytic activity of the complex and on the
properties of cofactors. Previous research showed that the bovine cyt
bc1 complex can be inactivated by delipidation, either by phospho-
lipase A2 treatment or by a chromatography method [21]. Reactivation
of the lipid-depleted bovine complex depended on addition of lipids,
in particular of phosphatidyl-ethanolamine and phosphatidyl-choline.
CL, which was not activating when added as single lipid, was needed
to stabilize the native structure of the complex [23,21]. Similarly,
delipidation nearly abolishes cyt c reductase activity of the yeast cytbc1 complex. The ﬁnding that the delipidated yeast complex could
only be fractionally activated by addition of CL alone is in full
agreement with previous reports on the reactivation of the bovine
complex [21]. For the yeast complex, maximum reactivation (∼70% of
the initial value) was achieved by addition of a mixture of asolectin
and CL.
Surprisingly, the spectral and electrochemical properties of the
heme b cofactors were dependent on the lipid content of the enzyme.
In the redox spectra of the delipidated enzyme, a blue shift of the
alpha-band maximum of cyt b of about 2 nmwas observed. This shift
proved to be reversible and lipid-dependent. Addition of the
asolectin/CL mixture, which provided maximum reactivation of the
delipidated complex, resulted in peak positions of the b-hemes that
were identical with the native enzyme. A small blue shift of 1.5–1.7 nm
was also reported for the delipidated bovine complex, but only if the
enzyme was repuriﬁed by chromatography [23]. Reversibility of that
shift was not shown and no changes in the spectral properties of the
delipidated bovine complex before repuriﬁcation were reported.
In addition to the lipid-dependent position of the b-heme
absorption maximum, the midpoint redox potentials of both b-
hemes, bH and bL, were also inﬂuenced by enzyme-bound lipids. The
Em of heme bL was shifted from−52 mV in the untreated complex to
−82 mV in the delipidated complex. Heme bL transfers electrons
released upon ubiquinol oxidation at the Qo site to heme bH. The shift
in the midpoint potential of heme bL affects the electron transfer in
the low potential chain. Addition of CL alone could only partly reverse
this shift (−42 mV). After addition of the asolectin/CL mixture, the
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This ﬁnding is in accordance with the analysis of the catalytic activity
and the peak position of the b-hemes in the redox spectra upon
delipidation and relipidation. Addition of asolectin or CL alone led
only to a minor increase of the turnover number, whereas a ∼70%
recovery was detected for the relipidation with the asolectin/CL
mixture. This phospholipid mixture could also completely reverse the
blue shift of the b-heme peak position in the redox spectra in contrast
to addition of asolectin and CL alone.
The effect of delipidation for heme bH was even more pronounced
than for heme bL as its Em shifted from 113 mV to−2 mV. This shift is
partially reversible when adding back CL or the asolectin/CL mixture,
though to a considerable lesser extent than in the case of heme bL.
Heme bH reduces quinone or the semiquinone radical at the Qi site
according to the Q cycle. The shift of the midpoint potential to more
negative values and the difference in the midpoint potential of heme
bH and bL, which is changed signiﬁcantly from the native (165 mV) to
the delipidated enzyme (80 mV), will decrease the driving force for
and the extent of electron transfer through the b-hemes to the Qi site.
This creates a disbalance between high and low potential chain which
could provoke generation of reactive oxygen species at the Qo site
[27,35,36]. How does the removal of lipids affect the midpoint
potential of the heme groups? One can safely assume that the lipid-
binding sites resolved in the crystal structures of the yeast cyt bc1
complex are also occupied in the puriﬁed complex as conﬁrmed by
analysis of extracted lipids from both samples (Richers and Hunte, in
prep). Clearly, more lipids are tightly bound in the vicinity of the Qi
site close to heme bH as compared to heme bL (Fig. 1A), in accordance
with the more pronounced effect of delipidation on the midpoint
potential of the former. Removal of neighbouring phosphatidyl-
ethanolamine and phosphatidyl-choline molecules will affect local
charge distribution and the electrostatic environment of the b-hemes,
yet, it is not known to which extent this may lower the midpoint
potentials. In addition, the observed differences will contribute to
lower cyt c reductase activity but do not explain the nearly complete
inactivation of the enzyme upon delipidation. The removal of lipids
and especially of CL may have caused structural perturbances but not
an irreversible damage as indicated by full reversibility of the spectral
properties of the heme b cofactors. This assumption is supported by an
electrochemically induced FTIR difference spectroscopy study which
demonstrated that the delipidated complex is stable but has a
perturbation in the spectral property typical for the protein backbone,
which can be partially reversed by relipidation [37]. Finally, loss of the
lipid layer on the surface of the quinone exchange cavity will very
likely impair access of the substrates to the active sites and may
thereby signiﬁcantly contribute to enzyme inactivation. The different
lipid-binding sites will therefore contribute differently to catalytic,
spectral and electrochemical properties of the yeast cyt bc1 complex. It
was shown that destabilization of the CLi-binding site by site-directed
mutagenesis impairs the functionality of the cyt bc1 complex [8].
Overall, the lipid complement is important for full functionality of the
complex but single binding sites have to be targeted to dissect their
individual contribution.
The CLi-binding site of the yeast cyt bc1 complex may also be
important for the supramolecular assembly with COX. Based on BN-
PAGE analysis of deletion variants of several subunits of individual
respiratory complexes, the CLi-binding site in the vicinity of the Qi site
(Fig. 1B) was suggested as the major interaction spot between the two
respiratory enzymes [26]. Single, double and triple replacement
variants of the lysine residues in the CLi-binding site in a CL-
synthesizing and CL-free environment were therefore investigated
to study the inﬂuence of the modiﬁcations in this site on supramo-
lecular association between cyt bc1 complex and COX. BN-PAGE
analysis revealed supramolecular assembly of the two enzymes in
mitochondrial membranes for all variants in the CL-containing
environment. In CL-free environment, supercomplex formationcould not be observed for the wild-type and the single replacement
variants in BN-PAGE. Surprisingly, supercomplex stability was found
largely restored in two double replacement variants (K288L/K289L
and K289L/K296L, but not in K288L/K296L) and in the triple
replacement variant. It seems that a parallel loss of two positive
charges in the CL-binding site – at the proposed interface between cyt
bc1 complex and COX – can neutralize the loss of two negative charges
due to lack of CL, and therefore can restore the stability of the
supercomplex association otherwise impeded by non-compensated
charges. The coordination pattern from the X-ray structure suggests
that the positive charge of only two of the three lysines in the CL-
binding motif is neutralized upon binding of the dianionic phospho-
lipid. Only under the condition of charge neutralization, CL seems to
be no longer required for stabilization of supercomplexes. This would
explain supercomplex stabilization in the double replacement
variants K288L/K289L and K289L/K296L in the CL-free environment.
This model is supported by the charge sensitivity of supercomplex
formation. Interpretation of the electrophoretic analysis is further
complicated by the possibility that other phospholipids like the acidic
CL precursor phosphatidyl-glycerol may alternatively bind to the CL-
binding site at the Qi site of the cyt bc1 complex.
5. Conclusion
This study provides direct evidence for the role of phospholipids
on the catalytic, spectral and electrochemical properties of the yeast
respiratory cyt bc1 complex and on its interaction with COX. Data
presented for the delipidated and relipidated enzyme indicate that
individual lipid-binding sites contribute in different ways to the
reversible inactivation of the enzyme. Polar lipid head groups may
inﬂuence the environment of the b-heme cofactors with effect on
absorption maxima, midpoint redox potential and catalytic activity.
The analysis of supercomplex formation suggests that CLi may serve as
a charge neutralizer for the lysine residues near the presumed
interaction domain between cyt bc1 complex and COX thereby
stabilising supercomplex formation. Overall, our study supports the
idea, that enzyme-bound phospholipids play an important role in
protein function.
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